Novartis (NVS) Stock Price, Quote, News & History | Benzinga

Novartis AG (NVS) Stock Price, Quote, News & History

NVSNYSE

Trade with Public

Trade with Public

$143.66

0.180.13%

At close: Jun 2, 5:00 PM EST

$145.36

1.881.31%

Pre-Market: 7:32 AM EST

OverviewNews Earnings Events Options Dividends Analyst Ratings Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

$143.66

Volume / Avg.

2.54K / 1.72M

Day Range

- - -

52 Wk Range

112.34 - 170.46

Market Cap

$277.36B

P/E Ratio

20.58

Dividend Yield

3.30%

Exchange

NYSE

RSI

44

Short Interest

0.23%

Days to Cover

3.52

Recent Novartis AG News

Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders

Relay Therapeutics reported early Phase 2 data showing lesion reduction and symptom improvement with zovegalisib.

Vandana Singh

Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'

Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.

Tanya Rawat

PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers

PTC Therapeutics stock drops after PIVOT-HD update, as FDA approval doubts offset dose-based benefits and stable safety signals.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

19.18B

Investing Cash Flow (TTM)

-16.94B

Financing Cash Flow (TTM)

-2.74B

Free Cash Flow (TTM)

15.96B

Capital Expenditure (TTM)

-3.21B

Net Change in Cash (TTM)

-508.00M

Analyst Trends and Forecast

1

Dec 25

1

Jan

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.4

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$317.95B

PE Ratio (TTM)

20.58

PE Ratio (FWD)

16.26

PEG Ratio (TTM)

3.87

PS Ratio (TTM)

4.92

PB Ratio (TTM)

7.12

Earnings Yield % (TTM)

4.86%

Earnings Yield % (FWD)

6.15%

EV / EBITDA (TTM)

14.05

Price / EBITDA (TTM)

12.44

Price / Free Cash Flow (TTM)

17.45

Book Value / Share

$20.18

Company Debt

Total Debt

$45.06B

LT Debt

$37.45B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$285.00M

Total Cash

$6.88B

Debt to Equity

1.22

Issuance of Debt (TTM)

$16.73B

Repayment of Debt (TTM)

-$2.69B

Key Statistics

Open

-

Close

$143.66

Volume / Avg.

2.54K / 1.72M

Day Range

- - -

52 Wk Range

112.34 - 170.46

Market Cap

$277.36B

P/E Ratio

20.58

Dividend Yield

3.30%

Exchange

NYSE

RSI

44

Short Interest

0.23%

Days to Cover

3.52

About

Sector

Health Care

Industry

Pharmaceuticals

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Novartis (NVS) stock?

A

You can purchase shares of Novartis (NYSE:NVS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Novartis (NVS) competitors?

A

There are no as such competitors for Novartis.

Q

What is the forecast, or price target, for Novartis (NVS) stock?

A

Novartis has a consensus price target of $134.50.

Q

What is the current price for Novartis (NVS)?

A

The stock price for Novartis (NYSE: NVS) is $145.36 last updated June 4, 2026 at 6:41 AM EDT.

Q

Does Novartis (NVS) pay a dividend?

A

There are no upcoming dividends for Novartis.

Q

When is Novartis (NYSE:NVS) reporting earnings?

A

Novartis does not have any upcoming earnings scheduled.

Q

Is Novartis (NVS) going to split?

A

There is no upcoming split for Novartis.

Q

What sector and industry does Novartis (NVS) operate in?

A

Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.